Our development laboratories are housed within our 6,500m² Deeside facility which can support a range of ADC services, from discovery to development.
Our bioconjugation team formed in 2011; moving into the state of the art Deeside, UK facility in 2018. The facility has been built for containment; with the safety of our people and the environment in mind, and our bespoke laboratories have been designed specifically to accommodate highly potent bioconjugations.
Download our facility spotlight here.
Fast facts
Established in 2011
60 employees
6,500m² facility
Discovery, development and clinical manufacturing
Our Deeside facility delivers more than 10 years of expertise in ADC discovery and development, as well as GMP clinical manufacturing.
Key services include:
- Bioconjugation
- Mass spectrometry
- Proof of concept
- Process development
- Process scale-up
- ADC clinical manufacturing
Our Deeside site is home to an array of specialised equipment for bioconjugation projects.
Key equipment includes:
- Glove box isolators, <2ng/m3
- AKTA chromatography systems
- Multiple vendor TFF systems with data logging
- Scalable reaction systems
- Agilent HPLCs with DAD and chilled autosamplers
- Sciex x500B QTOF mass spectrometer
- ProteinSimple Maurice for cIEF and CE-SDS
- UV/Vis spectrophotometry
- Multimodal plate readers for colorimetric and fluorescence assays
- Pressure cascade containment, vented cabinets, and 100% HEPA filtered exhausted air
Deeside Industrial Park, Unit 103 Tenth Ave, Deeside CH5 2UA
Click here for the full 360 tour.
